Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / Fund iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer Blackrock
Entity holding fund iShares VII Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF Ticker CUS1(GBX) LSE
ETF Ticker CUSS(USD) LSE
ETF Ticker SXRG(EUR) F
ETF Ticker CSUSS.MI(EUR) CXE
ETF Ticker CSUSSz(USD) CXE
ETF Ticker CUSS.LS(USD) CXE
ETF Ticker CSUSS(EUR) ETF Plus
ETF Ticker CUS1.L(GBP) LSE
ETF Ticker CUSS.L(GBP) LSE

Holdings detail for NRIX

Stock Name	Nurix Therapeutics Inc
Ticker	NRIX(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US67080M1036

Show aggregate NRIX holdings

News associated with NRIX

Nurix Therapeutics, Inc. (NASDAQ:NRIX) Receives $28.87 Consensus Target Price from Brokerages: Nurix Therapeutics, Inc. (NASDAQ:NRIX – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the sixteen research firms that are covering the company, MarketBeat.com reports. Three investment analysts have rated the stock with a hold recommendation and thirteen have assigned a buy recommendation to the company. The average 12-month price target […] - 2025-08-27 02:54:56
18,716 Shares in Nurix Therapeutics, Inc. (NASDAQ:NRIX) Purchased by XTX Topco Ltd: XTX Topco Ltd purchased a new position in shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX – Free Report) during the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 18,716 shares of the company’s stock, valued at approximately $222,000. Other institutional investors and hedge funds have also […] - 2025-08-13 04:26:46
TD Asset Management Inc Boosts Stake in Nurix Therapeutics, Inc. (NASDAQ:NRIX): TD Asset Management Inc increased its holdings in shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX – Free Report) by 8.1% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 42,420 shares of the company’s stock after purchasing an additional 3,186 […] - 2025-08-05 04:34:52
HC Wainwright Lowers Nurix Therapeutics (NASDAQ:NRIX) Price Target to $34.00: Nurix Therapeutics (NASDAQ:NRIX – Get Free Report) had its target price cut by equities research analysts at HC Wainwright from $36.00 to $34.00 in a report issued on Monday,Benzinga reports. The firm currently has a “buy” rating on the stock. HC Wainwright’s price objective would indicate a potential upside of 179.84% from the stock’s previous […] - 2025-07-16 04:26:52
Analysts Set Nurix Therapeutics, Inc. (NASDAQ:NRIX) Target Price at $30.18: Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX – Get Free Report) have received an average recommendation of “Moderate Buy” from the eighteen ratings firms that are currently covering the stock, Marketbeat.com reports. Three analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. The average 12 month […] - 2025-07-08 03:10:44
Nurix: European Medicines Agency Grants Orphan Drug Designation To Bexobrutideg: (RTTNews) - Nurix Therapeutics (NRIX) announced that the European Medicines Agency has granted Orphan Drug Designation to bexobrutideg for the treatment of lymphoplasmacytic lymphoma. Bexobrutideg is an orally bioavailable, brain penetrant degrader of Brutons tyrosine kinase whic - 2025-07-07 08:41:27
Sumitomo Mitsui Trust Group Inc. Sells 33,252 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX): Sumitomo Mitsui Trust Group Inc. reduced its position in Nurix Therapeutics, Inc. (NASDAQ:NRIX – Free Report) by 4.2% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 755,970 shares of the company’s stock after selling 33,252 shares during the […] - 2025-07-04 05:13:03
Brokerages Set Nurix Therapeutics, Inc. (NASDAQ:NRIX) Price Target at $30.18: Nurix Therapeutics, Inc. (NASDAQ:NRIX – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the eighteen research firms that are covering the company, Marketbeat reports. Three investment analysts have rated the stock with a hold recommendation and fifteen have issued a buy recommendation on the company. The average 12-month target price […] - 2025-06-13 02:32:51
The Math Shows ESML Can Go To $48: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-06-05 07:20:56
ProShare Advisors LLC Acquires 7,261 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX): ProShare Advisors LLC lifted its holdings in shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX – Free Report) by 45.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 23,132 shares of the company’s stock after buying an additional 7,261 shares during the period. […] - 2025-05-28 05:09:01
Brokerages Set Nurix Therapeutics, Inc. (NASDAQ:NRIX) Price Target at $30.44: Nurix Therapeutics, Inc. (NASDAQ:NRIX – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the nineteen ratings firms that are currently covering the firm, Marketbeat.com reports. Three investment analysts have rated the stock with a hold recommendation and sixteen have issued a buy recommendation on the company. The average 1-year price […] - 2025-05-19 02:32:50
First Trust Advisors LP Acquires New Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX): First Trust Advisors LP bought a new position in Nurix Therapeutics, Inc. (NASDAQ:NRIX – Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 135,903 shares of the company’s stock, valued at approximately $2,560,000. First Trust Advisors LP owned approximately […] - 2025-05-05 06:24:57
Invesco Ltd. Sells 361,360 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX): Invesco Ltd. lessened its position in shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX – Free Report) by 87.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 51,980 shares of the company’s stock after selling 361,360 shares during the quarter. Invesco Ltd.’s holdings […] - 2025-05-02 05:06:53
Norges Bank Purchases Shares of 318,800 Nurix Therapeutics, Inc. (NASDAQ:NRIX): Norges Bank acquired a new position in Nurix Therapeutics, Inc. (NASDAQ:NRIX – Free Report) in the 4th quarter, Holdings Channel.com reports. The firm acquired 318,800 shares of the company’s stock, valued at approximately $6,006,000. Other institutional investors also recently bought and sold shares of the company. NEOS Investment Management LLC purchased a new stake in […] - 2025-04-10 05:34:49
Vanguard Group Inc. Has $81.87 Million Stake in Nurix Therapeutics, Inc. (NASDAQ:NRIX): Vanguard Group Inc. boosted its stake in Nurix Therapeutics, Inc. (NASDAQ:NRIX – Free Report) by 8.3% during the 4th quarter, HoldingsChannel reports. The fund owned 4,345,266 shares of the company’s stock after acquiring an additional 333,452 shares during the quarter. Vanguard Group Inc. owned about 0.06% of Nurix Therapeutics worth $81,865,000 as of its most […] - 2025-04-10 04:44:59
Peek Under The Hood: DFAC Has 28% Upside: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-04-04 08:47:40
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Given Average Recommendation of “Moderate Buy” by Brokerages: Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX – Get Free Report) have received a consensus rating of “Moderate Buy” from the eighteen analysts that are presently covering the stock, MarketBeat.com reports. Three research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. The average 12-month price […] - 2025-03-27 04:38:49
US Bancorp DE Has $27,000 Stock Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX): US Bancorp DE raised its holdings in Nurix Therapeutics, Inc. (NASDAQ:NRIX – Free Report) by 144.7% in the 4th quarter, HoldingsChannel reports. The fund owned 1,424 shares of the company’s stock after acquiring an additional 842 shares during the period. US Bancorp DE’s holdings in Nurix Therapeutics were worth $27,000 at the end of the […] - 2025-03-20 06:28:53
Bank of New York Mellon Corp Purchases 15,639 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX): Bank of New York Mellon Corp lifted its position in shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX – Free Report) by 8.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 190,905 shares of the company’s stock after buying an additional 15,639 shares during the […] - 2025-03-20 06:28:53
Leerink Partners Initiates Coverage on Nurix Therapeutics (NASDAQ:NRIX): Leerink Partners began coverage on shares of Nurix Therapeutics (NASDAQ:NRIX – Free Report) in a report published on Monday morning, MarketBeat Ratings reports. The firm issued a market perform rating and a $16.00 price target on the stock. Several other equities analysts also recently commented on the company. HC Wainwright increased their price target on […] - 2025-03-18 04:30:53
Brokerages Set Nurix Therapeutics, Inc. (NASDAQ:NRIX) Target Price at $31.81: Nurix Therapeutics, Inc. (NASDAQ:NRIX – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the sixteen ratings firms that are covering the stock, Marketbeat reports. One investment analyst has rated the stock with a hold recommendation and fifteen have given a buy recommendation to the company. The average 1-year price objective […] - 2025-03-05 04:53:07
Rhumbline Advisers Acquires 12,315 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX): Rhumbline Advisers raised its stake in shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX – Free Report) by 13.5% during the fourth quarter, Holdings Channel reports. The firm owned 103,233 shares of the company’s stock after buying an additional 12,315 shares during the quarter. Rhumbline Advisers’ holdings in Nurix Therapeutics were worth $1,945,000 at the end of […] - 2025-03-04 06:10:55
Nurix Therapeutics (NASDAQ:NRIX) Stock Price Expected to Rise, Morgan Stanley Analyst Says: Nurix Therapeutics (NASDAQ:NRIX – Get Free Report) had its price objective lifted by analysts at Morgan Stanley from $16.00 to $17.00 in a research report issued to clients and investors on Monday,Benzinga reports. The firm presently has an “equal weight” rating on the stock. Morgan Stanley’s price target indicates a potential downside of 8.55% from […] - 2025-02-05 04:44:53

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc NRIX holdings

Date	Number of NRIX Shares Held	Base Market Value of NRIX Shares	Local Market Value of NRIX Shares	Change in NRIX Shares Held	Change in NRIX Base Value	Current Price per NRIX Share Held	Previous Price per NRIX Share Held
2026-01-15 (Thursday)	24,361	USD 459,448	USD 459,448	3,744	USD 66,900	USD 18.86	USD 19.04
2026-01-14 (Wednesday)	20,617	USD 392,548	USD 392,548	72	USD 3,631	USD 19.04	USD 18.93
2026-01-13 (Tuesday)	20,545	USD 388,917	USD 388,917	0	USD 11,300	USD 18.93	USD 18.38
2026-01-12 (Monday)	20,545	USD 377,617	USD 377,617	0	USD -18,902	USD 18.38	USD 19.3
2026-01-09 (Friday)	20,545	USD 396,519	USD 396,519	0	USD 13,766	USD 19.3	USD 18.63
2026-01-08 (Thursday)	20,545	USD 382,753	USD 382,753	72	USD 4,207	USD 18.63	USD 18.49
2026-01-07 (Wednesday)	20,473	USD 378,546	USD 378,546	0	USD 21,702	USD 18.49	USD 17.43
2026-01-06 (Tuesday)	20,473	USD 356,844	USD 356,844	0	USD -1,229	USD 17.43	USD 17.49
2026-01-05 (Monday)	20,473	USD 358,073	USD 358,073	0	USD -11,669	USD 17.49	USD 18.06
2026-01-02 (Friday)	20,473	USD 369,742	USD 369,742	0	USD -18,631	USD 18.06	USD 18.97
2025-12-31 (Wednesday)	20,473	USD 388,373	USD 388,373	0	USD -1,023	USD 18.97	USD 19.02

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of NRIX by Blackrock for IE00B3VWM098

Show aggregate share trades of NRIX

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2026-01-15 BUY 3,744 19.300 18.630 18.697 USD 70,002 15.01
2026-01-14 BUY 72 19.550 18.580 18.677 USD 1,345 15.00
2026-01-08 BUY 72 19.920 18.350 18.507 USD 1,333 14.93
2025-12-23 SELL -72 19.630 19.110 19.162 USD -1,380 14.76 Loss of -317 on sale
2025-12-03 SELL -360 17.460 16.250 16.371 USD -5,894 14.49 Loss of -676 on sale
2025-12-02 BUY 144 17.280 16.020 16.146 USD 2,325 14.49
2025-11-25 SELL -216 17.540 16.630 16.721 USD -3,612 14.42 Loss of -497 on sale
2025-11-24 SELL -216 17.650 16.750 16.840 USD -3,637 14.41 Loss of -526 on sale
2025-11-17 SELL -792 13.430 12.645 12.724 USD -10,077 14.41 Profit of 1,333 on sale
2025-11-12 SELL -72 13.150 12.150 12.250 USD -882 14.44 Profit of 157 on sale
2025-11-06 SELL -72 12.880 12.300 12.358 USD -890 14.48 Profit of 153 on sale
2025-11-05 SELL -720 13.030 11.980 12.085 USD -8,701 14.49 Profit of 1,730 on sale
2025-11-04 SELL -144 12.530 12.160 12.197 USD -1,756 14.50 Profit of 332 on sale
2025-11-03 SELL -144 13.180 12.280 12.370 USD -1,781 14.51 Profit of 308 on sale
2025-10-28 BUY 216 11.900 12.450 12.395 USD 2,677 14.56
2025-10-24 SELL -72 11.090 11.220 11.207 USD -807 14.59 Profit of 244 on sale
2025-10-15 BUY 432 10.350 10.430 10.422 USD 4,502 14.76
2025-10-02 BUY 72 9.080 9.690 9.629 USD 693 14.82
2025-09-30 BUY 144 9.240 9.410 9.393 USD 1,353 14.89
2025-08-21 SELL -72 9.650 9.695 9.690 USD -698 15.07 Profit of 387 on sale
2025-07-31 BUY 216 11.260 11.670 11.629 USD 2,512 15.12
2025-06-30 SELL -144 11.390 11.965 11.908 USD -1,715 15.52 Profit of 521 on sale
2025-06-25 SELL -72 11.620 11.985 11.948 USD -860 15.60 Profit of 263 on sale
2025-06-20 SELL -144 11.490 11.880 11.841 USD -1,705 15.68 Profit of 554 on sale
2025-05-23 BUY 72 9.720 9.860 9.846 USD 709 16.38
2025-05-19 SELL -72 9.510 9.670 9.654 USD -695 16.60 Profit of 500 on sale
2025-05-15 SELL -216 9.460 9.670 9.649 USD -2,084 16.73 Profit of 1,529 on sale
2025-05-12 SELL -72 10.180 10.380 10.360 USD -746 16.91 Profit of 472 on sale
2025-05-09 SELL -72 9.500 10.030 9.977 USD -718 16.98 Profit of 504 on sale
2025-04-30 SELL -72 11.530 11.720 11.701 USD -842 17.42 Profit of 412 on sale
2025-04-24 SELL -144 11.520 11.750 11.727 USD -1,689 17.66 Profit of 854 on sale
2025-04-17 SELL -72 10.240 10.265 10.263 USD -739 18.02 Profit of 559 on sale
2025-04-15 SELL -216 9.820 10.165 10.130 USD -2,188 18.20 Profit of 1,744 on sale
2025-04-14 SELL -216 9.850 9.970 9.958 USD -2,151 18.30 Profit of 1,801 on sale
2025-04-09 SELL -288 9.600 10.160 10.104 USD -2,910 18.61 Profit of 2,448 on sale
2025-04-07 SELL -504 9.720 9.910 9.891 USD -4,985 18.82 Profit of 4,499 on sale
2025-04-04 SELL -720 9.690 10.520 10.437 USD -7,515 18.93 Profit of 6,111 on sale
2025-03-31 BUY 72 11.880 12.030 12.015 USD 865 19.21
2025-03-19 SELL -144 13.900 14.060 14.044 USD -2,022 19.88 Profit of 840 on sale
2025-03-14 SELL -432 13.590 13.640 13.635 USD -5,890 20.14 Profit of 2,808 on sale
2025-03-13 SELL -146 13.190 14.670 14.522 USD -2,120 20.23 Profit of 834 on sale
2025-03-12 SELL -2,482 14.540 14.870 14.837 USD -36,825 20.32 Profit of 13,601 on sale
2025-03-07 SELL -146 13.860 14.290 14.247 USD -2,080 20.61 Profit of 930 on sale
2025-03-06 SELL -219 14.050 14.430 14.392 USD -3,152 20.72 Profit of 1,385 on sale
2025-03-03 SELL -73 14.190 15.510 15.378 USD -1,123 21.03 Profit of 412 on sale
2025-02-28 SELL -438 15.450 15.460 15.459 USD -6,771 21.12 Profit of 2,479 on sale
2025-02-26 SELL -73 17.060 17.210 17.195 USD -1,255 21.29 Profit of 299 on sale
2025-02-25 SELL -219 16.470 16.980 16.929 USD -3,707 21.38 Profit of 974 on sale
2025-02-18 BUY 365 16.730 18.070 17.936 USD 6,547 21.79
2025-02-13 BUY 73 17.570 17.850 17.822 USD 1,301 22.04
2025-02-12 BUY 73 17.310 17.350 17.346 USD 1,266 22.14
2025-02-11 BUY 219 17.120 18.180 18.074 USD 3,958 22.24
2025-02-06 BUY 657 19.040 19.530 19.481 USD 12,799 22.48
2025-01-27 BUY 73 19.810 20.660 20.575 USD 1,502 23.14
2024-12-30 BUY 365 18.640 19.085 19.040 USD 6,950 23.58
2024-12-06 BUY 292 21.370 22.080 22.009 USD 6,427 23.81
2024-12-05 BUY 73 20.060 21.340 21.212 USD 1,548 23.94
2024-12-04 BUY 365 20.820 21.290 21.243 USD 7,754 24.05
2024-11-29 BUY 360 22.110 22.230 22.218 USD 7,998 24.35
2024-11-27 BUY 288 21.230 22.100 22.013 USD 6,340 24.62
2024-11-26 BUY 72 21.790 22.080 22.051 USD 1,588 24.75
2024-11-25 SELL -42,323 21.820 22.790 22.693 USD -960,436 24.89 Profit of 93,125 on sale
2024-11-21 BUY 1,000 22.370 23.090 23.018 USD 23,018 25.18
2024-11-20 BUY 600 22.640 22.880 22.856 USD 13,714 25.32
2024-11-18 BUY 2,400 21.790 22.710 22.618 USD 54,283 25.70
2024-11-12 BUY 1,600 27.030 28.200 28.083 USD 44,933 25.61
2024-11-08 BUY 1,000 27.340 27.750 27.709 USD 27,709 25.48
2024-11-07 BUY 3,000 27.240 28.420 28.302 USD 84,906 25.35
2024-11-06 BUY 400 27.000 27.275 27.247 USD 10,899 25.21
2024-10-31 BUY 200 24.580 24.940 24.904 USD 4,981 25.37
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2026-01-15	BUY	3,744	19.300	18.630	18.697	USD 70,002	15.01
2026-01-14	BUY	72	19.550	18.580	18.677	USD 1,345	15.00
2026-01-08	BUY	72	19.920	18.350	18.507	USD 1,333	14.93
2025-12-23	SELL	-72	19.630	19.110	19.162	USD -1,380	14.76 Loss of -317 on sale
2025-12-03	SELL	-360	17.460	16.250	16.371	USD -5,894	14.49 Loss of -676 on sale
2025-12-02	BUY	144	17.280	16.020	16.146	USD 2,325	14.49
2025-11-25	SELL	-216	17.540	16.630	16.721	USD -3,612	14.42 Loss of -497 on sale
2025-11-24	SELL	-216	17.650	16.750	16.840	USD -3,637	14.41 Loss of -526 on sale
2025-11-17	SELL	-792	13.430	12.645	12.724	USD -10,077	14.41 Profit of 1,333 on sale
2025-11-12	SELL	-72	13.150	12.150	12.250	USD -882	14.44 Profit of 157 on sale
2025-11-06	SELL	-72	12.880	12.300	12.358	USD -890	14.48 Profit of 153 on sale
2025-11-05	SELL	-720	13.030	11.980	12.085	USD -8,701	14.49 Profit of 1,730 on sale
2025-11-04	SELL	-144	12.530	12.160	12.197	USD -1,756	14.50 Profit of 332 on sale
2025-11-03	SELL	-144	13.180	12.280	12.370	USD -1,781	14.51 Profit of 308 on sale
2025-10-28	BUY	216	11.900	12.450	12.395	USD 2,677	14.56
2025-10-24	SELL	-72	11.090	11.220	11.207	USD -807	14.59 Profit of 244 on sale
2025-10-15	BUY	432	10.350	10.430	10.422	USD 4,502	14.76
2025-10-02	BUY	72	9.080	9.690	9.629	USD 693	14.82
2025-09-30	BUY	144	9.240	9.410	9.393	USD 1,353	14.89
2025-08-21	SELL	-72	9.650	9.695	9.690	USD -698	15.07 Profit of 387 on sale
2025-07-31	BUY	216	11.260	11.670	11.629	USD 2,512	15.12
2025-06-30	SELL	-144	11.390	11.965	11.908	USD -1,715	15.52 Profit of 521 on sale
2025-06-25	SELL	-72	11.620	11.985	11.948	USD -860	15.60 Profit of 263 on sale
2025-06-20	SELL	-144	11.490	11.880	11.841	USD -1,705	15.68 Profit of 554 on sale
2025-05-23	BUY	72	9.720	9.860	9.846	USD 709	16.38
2025-05-19	SELL	-72	9.510	9.670	9.654	USD -695	16.60 Profit of 500 on sale
2025-05-15	SELL	-216	9.460	9.670	9.649	USD -2,084	16.73 Profit of 1,529 on sale
2025-05-12	SELL	-72	10.180	10.380	10.360	USD -746	16.91 Profit of 472 on sale
2025-05-09	SELL	-72	9.500	10.030	9.977	USD -718	16.98 Profit of 504 on sale
2025-04-30	SELL	-72	11.530	11.720	11.701	USD -842	17.42 Profit of 412 on sale
2025-04-24	SELL	-144	11.520	11.750	11.727	USD -1,689	17.66 Profit of 854 on sale
2025-04-17	SELL	-72	10.240	10.265	10.263	USD -739	18.02 Profit of 559 on sale
2025-04-15	SELL	-216	9.820	10.165	10.130	USD -2,188	18.20 Profit of 1,744 on sale
2025-04-14	SELL	-216	9.850	9.970	9.958	USD -2,151	18.30 Profit of 1,801 on sale
2025-04-09	SELL	-288	9.600	10.160	10.104	USD -2,910	18.61 Profit of 2,448 on sale
2025-04-07	SELL	-504	9.720	9.910	9.891	USD -4,985	18.82 Profit of 4,499 on sale
2025-04-04	SELL	-720	9.690	10.520	10.437	USD -7,515	18.93 Profit of 6,111 on sale
2025-03-31	BUY	72	11.880	12.030	12.015	USD 865	19.21
2025-03-19	SELL	-144	13.900	14.060	14.044	USD -2,022	19.88 Profit of 840 on sale
2025-03-14	SELL	-432	13.590	13.640	13.635	USD -5,890	20.14 Profit of 2,808 on sale
2025-03-13	SELL	-146	13.190	14.670	14.522	USD -2,120	20.23 Profit of 834 on sale
2025-03-12	SELL	-2,482	14.540	14.870	14.837	USD -36,825	20.32 Profit of 13,601 on sale
2025-03-07	SELL	-146	13.860	14.290	14.247	USD -2,080	20.61 Profit of 930 on sale
2025-03-06	SELL	-219	14.050	14.430	14.392	USD -3,152	20.72 Profit of 1,385 on sale
2025-03-03	SELL	-73	14.190	15.510	15.378	USD -1,123	21.03 Profit of 412 on sale
2025-02-28	SELL	-438	15.450	15.460	15.459	USD -6,771	21.12 Profit of 2,479 on sale
2025-02-26	SELL	-73	17.060	17.210	17.195	USD -1,255	21.29 Profit of 299 on sale
2025-02-25	SELL	-219	16.470	16.980	16.929	USD -3,707	21.38 Profit of 974 on sale
2025-02-18	BUY	365	16.730	18.070	17.936	USD 6,547	21.79
2025-02-13	BUY	73	17.570	17.850	17.822	USD 1,301	22.04
2025-02-12	BUY	73	17.310	17.350	17.346	USD 1,266	22.14
2025-02-11	BUY	219	17.120	18.180	18.074	USD 3,958	22.24
2025-02-06	BUY	657	19.040	19.530	19.481	USD 12,799	22.48
2025-01-27	BUY	73	19.810	20.660	20.575	USD 1,502	23.14
2024-12-30	BUY	365	18.640	19.085	19.040	USD 6,950	23.58
2024-12-06	BUY	292	21.370	22.080	22.009	USD 6,427	23.81
2024-12-05	BUY	73	20.060	21.340	21.212	USD 1,548	23.94
2024-12-04	BUY	365	20.820	21.290	21.243	USD 7,754	24.05
2024-11-29	BUY	360	22.110	22.230	22.218	USD 7,998	24.35
2024-11-27	BUY	288	21.230	22.100	22.013	USD 6,340	24.62
2024-11-26	BUY	72	21.790	22.080	22.051	USD 1,588	24.75
2024-11-25	SELL	-42,323	21.820	22.790	22.693	USD -960,436	24.89 Profit of 93,125 on sale
2024-11-21	BUY	1,000	22.370	23.090	23.018	USD 23,018	25.18
2024-11-20	BUY	600	22.640	22.880	22.856	USD 13,714	25.32
2024-11-18	BUY	2,400	21.790	22.710	22.618	USD 54,283	25.70
2024-11-12	BUY	1,600	27.030	28.200	28.083	USD 44,933	25.61
2024-11-08	BUY	1,000	27.340	27.750	27.709	USD 27,709	25.48
2024-11-07	BUY	3,000	27.240	28.420	28.302	USD 84,906	25.35
2024-11-06	BUY	400	27.000	27.275	27.247	USD 10,899	25.21
2024-10-31	BUY	200	24.580	24.940	24.904	USD 4,981	25.37

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of NRIX

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	76,869	0	337,089	22.8%
2025-09-18	115,926	97	470,434	24.6%
2025-09-17	126,671	0	672,961	18.8%
2025-09-16	103,850	0	416,879	24.9%
2025-09-15	262,191	0	512,074	51.2%
2025-09-12	144,962	0	456,366	31.8%
2025-09-11	113,184	0	213,493	53.0%
2025-09-10	110,091	853	183,502	60.0%
2025-09-09	136,763	0	288,470	47.4%
2025-09-08	123,946	5	228,588	54.2%
2025-09-05	123,937	0	238,538	52.0%
2025-09-04	72,940	0	129,918	56.1%
2025-09-03	181,068	0	299,306	60.5%
2025-09-02	76,510	0	353,687	21.6%
2025-08-29	203,278	42	356,573	57.0%
2025-08-28	55,246	0	151,084	36.6%
2025-08-27	71,617	3,905	118,660	60.4%
2025-08-26	86,489	20	165,947	52.1%
2025-08-25	41,394	0	100,220	41.3%
2025-08-22	65,645	0	165,093	39.8%
2025-08-21	58,041	166	177,377	32.7%
2025-08-20	67,997	0	191,754	35.5%
2025-08-19	97,083	865	296,240	32.8%
2025-08-18	80,471	0	1,066,527	7.5%
2025-08-15	59,912	0	124,040	48.3%
2025-08-14	79,225	0	116,844	67.8%
2025-08-13	97,433	0	177,943	54.8%
2025-08-12	73,474	77	151,976	48.3%
2025-08-11	103,917	53	233,589	44.5%
2025-08-08	85,699	0	162,586	52.7%
2025-08-07	70,588	0	116,889	60.4%
2025-08-06	215,458	41	268,136	80.4%
2025-08-05	78,095	0	149,090	52.4%
2025-08-04	70,141	4	117,121	59.9%
2025-08-01	99,674	85	116,924	85.2%
2025-07-31	218,945	0	624,755	35.0%
2025-07-30	162,585	4,925	194,367	83.6%
2025-07-29	180,029	442	376,034	47.9%
2025-07-28	251,755	0	464,585	54.2%
2025-07-25	78,115	26	128,306	60.9%
2025-07-24	89,575	429	240,857	37.2%
2025-07-23	79,373	0	288,378	27.5%
2025-07-22	102,193	0	188,093	54.3%
2025-07-21	81,204	0	127,391	63.7%
2025-07-18	156,582	1,615	261,963	59.8%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer	Blackrock
Entity holding fund	iShares VII Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300Q7FFITMZ2PFZ28
ETF Ticker	CUS1(GBX) LSE
ETF Ticker	CUSS(USD) LSE
ETF Ticker	SXRG(EUR) F
ETF Ticker	CSUSS.MI(EUR) CXE
ETF Ticker	CSUSSz(USD) CXE
ETF Ticker	CUSS.LS(USD) CXE
ETF Ticker	CSUSS(EUR) ETF Plus
ETF Ticker	CUS1.L(GBP) LSE
ETF Ticker	CUSS.L(GBP) LSE